Fund shareholders of TherapeuticsMD Inc
ISIN US88338N2062 · United States · LEI 5299004JS7RE49QHRW30
- Fund shareholders
- 12
- Of which ETFs
- 1 11 other funds
- Value held
- 992.5K $
- Share of capital
- 4.1 % of 11.6M shares on Aug 9, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 244,317 | 493.5K $ | 2.11 % | as of Mar 31, 2026 ↗ | |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 109,380 | 220.9K $ | 0.00 % | 0.95 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 67,220 | 151.9K $ | 0.00 % | 0.58 % | as of Feb 28, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 17,000 | 34.3K $ | 0.03 % | 0.15 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 15,320 | 34.6K $ | 0.13 % | as of Feb 28, 2026 ↗ | |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 14,835 | 33.5K $ | 0.13 % | as of Feb 28, 2026 ↗ | |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 4,826 | 9.8K $ | 0.04 % | as of Apr 30, 2026 ↗ | |
| The Gabelli ABC Fund Gabelli Investor Funds Inc | 3,600 | 7.3K $ | 0.00 % | 0.03 % | as of Mar 31, 2026 ↗ |
| U.S. CORE EQUITY 1 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 1,063 | 2.2K $ | 0.01 % | as of Apr 30, 2026 ↗ | |
| Enterprise Mergers and Acquisitions Fund Gabelli 787 Fund, Inc. | 1,000 | 2K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Diversified Equity Master Portfolio Master Investment Portfolio | 745 | 1.5K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| U.S. CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 418 | 852.7 $ | 0.00 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.03 % | as of Mar 31, 2026 ↗ |
| Enterprise Mergers and Acquisitions Fund Gabelli 787 Fund, Inc. | 0.00 % | as of Mar 31, 2026 ↗ |
| The Gabelli ABC Fund Gabelli Investor Funds Inc | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| Diversified Equity Master Portfolio Master Investment Portfolio | 0.00 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 12 | +1 | 479,724 | +6.4 % |
| 2026Q1 | 11 | 0 | 451,065 | -3.8 % |
| 2025Q4 | 11 | -1 | 468,878 | -9.1 % |
| 2025Q3 | 12 | -1 | 515,827 | -0.5 % |
| 2025Q2 | 13 | -1 | 518,323 | -1.8 % |
| 2025Q1 | 14 | -2 | 527,826 | +0.1 % |
| 2024Q4 | 16 | -2 | 527,298 | -2.3 % |
| 2024Q3 | 18 | 0 | 539,915 | -1.1 % |
| 2024Q2 | 18 | -3 | 545,954 | -2.8 % |
| 2024Q1 | 21 | -2 | 561,852 | -6.9 % |
| 2023Q4 | 23 | 603,712 |
Institutional managers
44 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Rubric Capital Management LP | 1,192,191 | 2.4M $ | as of Mar 31, 2026 |
| Clearline Capital LP | 635,222 | 1.3M $ | as of Mar 31, 2026 |
| Squadron Capital Management LLC | 420,421 | 849.3K $ | as of Mar 31, 2026 |
| Tejara Capital Ltd | 345,852 | 698.6K $ | as of Mar 31, 2026 |
| ADAR1 Capital Management, LLC | 209,210 | 422.6K $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 146,200 | 295.3K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 129,217 | 261K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 115,145 | 232.6K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 109,817 | 221.9K $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 68,314 | 138K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 30,100 | 60.8K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 27,487 | 55.5K $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 21,220 | 42.9K $ | as of Mar 31, 2026 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 17,000 | 34.3K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 16,093 | 32.5K $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 10,706 | 21.6K $ | as of Mar 31, 2026 |
| Cygnus Capital Advisors, LLC | 9,069 | 18 $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 1,509 | 3K $ | as of Mar 31, 2026 |
| NATIONAL BANK OF CANADA /FI/ | 610 | 1.2K $ | as of Mar 31, 2026 |
| Smartleaf Asset Management LLC | 601 | 1.2K $ | as of Mar 31, 2026 |
| UBS Group AG | 331 | 669 $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 293 | 583 $ | as of Mar 31, 2026 |
| SBI Securities Co., Ltd. | 267 | 539 $ | as of Mar 31, 2026 |
| US BANCORP \DE\ | 246 | 497 $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 226 | 457 $ | as of Mar 31, 2026 |
Declared shareholders of TherapeuticsMD Inc
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Baselake Partners, LP and 2 others | 5.20 % | 607,181 | as of Mar 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of TherapeuticsMD Inc". https://titelia.com/en/stocks/therapeuticsmd-inc-US88338N2062